Commercialisation of medical innovations

Between an invention and, finally, a new medical product there is a vast amount of innovation to do.  Whilst the invention is important (it is the spark that enables the innovation, after all), it is not intrinsically where the true commercial value lies; that is determined by a host of other considerations, many of which can be anticipated and exploited to increase the chances of a positive commercial outcome in the longer term.

In this interactive talk, Dr Michael Murray RTTP, will outline how a good idea leaves the campus and gets into the commercial world.  Great emphasis will be placed on looking way beyond the “invention” at the outset, the best to understand what the related innovation process must achieve, and how to do this in the context of developing new medical interventions whether they be new drugs, biologics, medical devices, instruments, diagnostics, or enabling technology platforms.  The material will cover inventions, the role of IP, how to inform market-aligned innovation and product development, and different mechanisms of the commercialisation process itself. Dr Murray will be available after the formal session if you wish to have a one-to-one conversation.

Facilitator/Lead Presenter(s):  Michael Murray

Hosted by:  Innovation Funding Team.  Please direct any queries to Neil Bowden

Session audience:  Early Career Researchers (ECRs); Mid Career Researchers (MCRs) working on medical innovations – e.g. medical devices, diagnostics, treatments, etc.

Book a place via Eventbrite

RDF Sub-domain(s):  C3 – Finance, Funding and Resources; D3 – Engagement and Impact;